Related Experiment Videos
Application of pharmaceuticals to nitric oxide
1Department of Biochemistry and Molecular Biology (Hampstead Site, Royal Free Campus), Rowland Hill Street, Royal Free and University College Medical School, London NW3 2PF, United Kingdom. lows@rfc.ucl.ac.uk
Molecular Aspects of Medicine
|February 22, 2005
Summary
Nitric oxide (NO) is a key mediator involved in various diseases. This review explores pharmaceutical strategies to modulate NO production, including NO donors, synthase inhibitors, and gene therapy, for therapeutic benefit.
Area of Science:
- Biomedical Science
- Pharmacology
- Physiology
Background:
- Nitric oxide (NO) acts as a crucial physiological mediator.
- Both NO deficiency and excess are linked to numerous disease states.
- Targeting NO production offers significant therapeutic potential.
Purpose of the Study:
- To review current pharmaceutical developments for modulating nitric oxide (NO) production.
- To discuss NO donor treatments, nitric oxide synthase inhibition, and gene therapy.
- To explore emerging strategies for promoting NO production and challenges with NO inhibitors.
Main Methods:
- Literature review of pharmaceutical development and application in NO modulation.
- Analysis of NO donor treatments, nitric oxide synthase inhibitors, and gene therapy approaches.
- Discussion of recent advancements and associated problems in NO-targeted therapies.
Main Results:
- Various pharmaceutical strategies are being developed to control NO levels.
- NO donor treatments, synthase inhibition, and gene therapy represent key areas of focus.
- Recent progress in promoting NO production and challenges with NO inhibitors are highlighted.
Conclusions:
- Pharmacological manipulation of NO holds promise for diverse therapeutic applications.
- The specificity and efficacy of NO-targeted interventions require further investigation.
- Future research will determine the broad therapeutic utility versus non-specific effects of NO modulation.